| |
| |
|
| Insider
Information: |
Martin Samuel Bates |
| Relationship: |
|
| City: |
Hampton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
35,128 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,275,146 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
35,128 |
|
|
| Total
Value |
$1,275,146 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
-3.0
|
| Percentage
Gain/Loss : |
 900.3%
|
 -54.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Celldex Therapeutics Inc |
CLDX |
|
2024-01-02 |
35,128 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLDX |
Celldex Therapeutics Inc |
SVP AND CFO |
• – – |
2024-01-02 |
4 |
OE |
$2.78 |
$29,885 |
D/D |
10,750 |
35,128 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
SVP AND CFO |
• – – |
2022-08-12 |
4 |
S |
$34.62 |
$639,629 |
D/D |
(17,547) |
24,378 |
0 |
% |
|
| CLDX |
Celldex Therapeutics Inc |
SVP AND CFO |
• – – |
2022-08-12 |
4 |
OE |
$2.78 |
$72,953 |
D/D |
17,547 |
41,925 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
SVP AND CFO |
• – – |
2022-08-11 |
4 |
S |
$37.04 |
$90,856 |
D/D |
(2,453) |
24,378 |
0 |
% |
|
| CLDX |
Celldex Therapeutics Inc |
SVP AND CFO |
• – – |
2022-08-11 |
4 |
OE |
$9.02 |
$22,117 |
D/D |
2,453 |
26,831 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
SVP and CFO |
• – – |
2021-12-23 |
4 |
AS |
$42.00 |
$399,000 |
D/D |
(9,500) |
24,378 |
0 |
% |
|
| CLDX |
Celldex Therapeutics Inc |
SVP and CFO |
• – – |
2021-12-23 |
4 |
OE |
$2.78 |
$39,729 |
D/D |
7,000 |
33,878 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
SVP and CFO |
• – – |
2021-11-15 |
4 |
AS |
$42.27 |
$413,883 |
D/D |
(9,500) |
26,878 |
0 |
% |
|
| CLDX |
Celldex Therapeutics Inc |
SVP and CFO |
• – – |
2021-11-15 |
4 |
OE |
$2.78 |
$39,729 |
D/D |
7,000 |
36,378 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
SVP and CFO |
• – – |
2021-08-10 |
4 |
S |
$45.25 |
$123,895 |
D/D |
(2,738) |
29,378 |
0 |
% |
|
| CLDX |
Celldex Therapeutics Inc |
SVP and CFO |
• – – |
2021-08-10 |
4 |
OE |
$2.78 |
$123,688 |
D/D |
21,381 |
30,060 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
SVP and CFO |
• – – |
2020-06-09 |
4 |
B |
$3.05 |
$29,738 |
D/D |
9,750 |
10,735 |
2.74 |
% |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
